Care of the pacemaker/implantable cardioverter defibrillator patient in the ED

American Journal of Emergency Medicine

Volumn 25, Issue 7, 2007, Pages 812-822

  McMullan, Jason ^a   Valento, Matthew ^a   Attari, Mehran ^a   Venkat, Arvind ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SUXAMETHONIUM;

ARTIFICIAL HEART PACEMAKER; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOVASCULAR DISEASE; CAUTERIZATION; CENTRAL VENOUS CATHETERIZATION; DEFIBRILLATION; DEFIBRILLATOR; DEVICE; DEVICE EXAMINATION; DEVICE INFECTION; DEVICE INTERROGATION; DEVICE MALFUNCTION; DO NOT RESUSCITATE ORDER; ELECTRICAL STORM; ELECTROMAGNETIC FIELD; EMERGENCY CARE; EMERGENCY PHYSICIAN; FASCICULATION; HEART ARREST; HEART MUSCLE ISCHEMIA; HEMATOMA; HUMAN; INTERVIEW; MAGNETISM; MOBILE PHONE; NUCLEAR MAGNETIC RESONANCE IMAGING; PACEMAKER MEDIATED TACHYCARDIA; PACEMAKER SYNDROME; PHYSICAL EXAMINATION; PRIORITY JOURNAL; REVIEW; RUNAWAY PACEMAKER; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; TACHYCARDIA; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TWIDDLER SYNDROME;

DEFIBRILLATORS, IMPLANTABLE; EMERGENCY MEDICAL SERVICES; EQUIPMENT FAILURE; HEART DISEASES; HUMANS; PACEMAKER, ARTIFICIAL;

EID: 34548533684     PISSN: 07356757     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajem.2007.02.008     Document Type: Review

References (46)

1. Brown D., Croft J., Giles W., et al. Epidemiology of pacemaker procedures among medicare enrollees in 1990, 1995, and 2000. Am J Cardiol 95 3 (2005) 409-411
2. Kusumoto F., and Goldschlager N. Device therapy for cardiac arrhythmias. JAMA 287 14 (2002) 1848-1852
3. Gregoratos G., Abrams J., Epstein A., et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article. J Cardiovasc Electrophysiol 13 11 (2002) 1183-1199
4. Scher D. Troubleshooting pacemakers and implantable cardioverter-defibrillators. Curr Opin Cardiol 19 1 (2004) 36-46
5. Trohman R., Kim M., and Pinski S. Cardiac pacing: the state of the art. Lancet 364 9446 (2004) 1701-1719
6. Pavia S., and Wilkoff B. The management of surgical complications of pacemaker and implantable cardioverter-defibrillators. Curr Opin Cardiol 16 1 (2001) 66-71
7. Cardall T., Brady W., Chan T., et al. Permanent cardiac pacemakers: issues relevant to the emergency physician, part I. J Emerg Med 17 3 (1999) 479-489
8. Burney K., Burchard F., Papouchado M., et al. Cardiac pacing systems and implantable cardiac defibrillators (ICDs): a radiological perspective of equipment, anatomy and complications. Clin Radiol 59 8 (2004) 699-708
9. Byrd C. Management of implant complications. In: Ellenbogen K., Kay G., and Wilkoff B. (Eds). Clinical cardiac pacing (1995), W.B. Saunders, Philadelphia 669-694
10. Klug D., Lacroix D., Savoye C., et al. Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management. Circulation 15 95 8 (1997) 2098-2107
11. Bhatta L., Luck J., Wolbrette D., et al. Complications of biventricular pacing. Curr Opin Cardiol 19 1 (2004) 31-35
12. Harper R., Brady W., Perron A., et al. The paced electrocardiogram: issues for the emergency physician. Am J Emerg Med 19 7 (2001) 551-560
13. Sarko J., and Tiffany B. Cardiac pacemakers: evaluation and management of malfunctions. Am J Emerg Med 18 4 (2000) 435-440
14. Cardall T., Brady W., Chan T., et al. Permanent cardiac pacemakers: issues relevant to the emergency physician, part II. J Emerg Med 17 4 (1999) 697-709
15. Stone K., and McPherson C. Assessment and management of patients with pacemakers and implantable cardioverter defibrillators. Crit Care Med 32 4 Suppl (2004) S155-S165
16. Finfer S. Pacemaker failure on induction of anaesthesia. Br J Anaesth 66 4 (1991) 509-512
17. Fishberger S., Mehta D., Rossi A., et al. Variable effects of adenosine on retrograde conduction in patients with atrioventricular nodal reentry tachycardia. Pacing Clin Electrophysiol 21 (1998) 1254-1257
18. Sobel R., Donaldson P., and Dhruva N. Pacemaker-mediated tachycardia: management by pacemaker interrogation/reprogramming in the ED. Am J Emerg Med 20 4 (2002) 336-339
19. Sgarbossa E., Pinski S., Barbagelata A., et al. Electrocardiographic diagnosis of evolving myocardial infarction in the presence of left bundle branch block. N Engl J Med 334 (1996) 481-487
20. Sweesy M., Holland J., and Smith K. Electromagnetic interference in cardiac rhythm management devices. AACN Clin Issues 15 3 (2004) 391-403
21. Stevenson W., Chaitman B., Ellenbogen K., et al. Clinical assessment and management of patients with implanted cardioverter-defibrillators presenting to nonelectrophysiologists. Circulation 21110 25 (2004) 3866-3869
22. Glikson M., and Friedman P. The implantable cardioverter defibrillator. Lancet 357 9262 (2001) 1107-1117
23. Pinski S. Emergencies related to implantable cardioverter-defibrillators. Crit Care Med 28 10 Suppl (2000) N174-N180
24. Ellenbogen K.L., Berger R., Daubert J., et al. Are implantable cardioverter defibrillator shocks a surrogate for sudden cardiac death in patients with nonischemic cardiomyopathy?. Circulation 113 6 (2006) 776-782
25. McPherson C., and Manthous C. Permanent pacemakers and implantable defibrillators: considerations for intensivists. Am J Respir Crit Care Med 170 9 (2004) 933-940
26. Eysmann S., Marchlinski F., Buxton A., et al. Electrocardiographic changes after cardioversion of ventricular arrhythmias. Circulation 73 1 (1986) 73-81
27. Gurevitz O.L., Yaacoby E., Segal E., et al. ST-segment deviation following implantable cardioverter defibrillator shocks: incidence, timing, and clinical significance. Pacing Clin Electrophysiol 25 10 (2002) 1429-1432
28. Hurst T., Hinrichs M., Breidenbach C., et al. Detection of myocardial injury during transvenous implantation of automatic cardioverter-defibrillators. J Am Coll Cardiol 34 2 (1999) 402-408
29. Naehle C., Sommer T., Meyer C., et al. Strategy for safe performance of magnetic resonance imaging on a patient with implantable cardioverter defibrillator. Pacing Clin Electrophysiol 29 1 (2006) 113-116
30. Arya A., Haghjoo M., Dehghani M., et al. Prevalence and predictors of electrical storm in patients with implantable cardioverter-defibrillator. Am J Cardiol 97 3 (2006) 389-392
31. Credner S., Klingenheben T., Mauss O., et al. Electrical storm in patients with transvenous implantable cardioverter-defibrillators: incidence, management and prognostic implications. J Am Coll Cardiol 32 7 (1998) 1909-1915
32. Exner D.P., Wyse D., Renfroe E., et al. Antiarrhythmics versus implantable defibrillators. Electrical storm presages nonsudden death: the antiarrhythmics versus implantable defibrillator (AVID) trial. Circulation 103 16 (2001) 2066-2071
33. Aizawa Y., Chinushi M., and Washizuka T. Indications for an implantable cardioverter defibrillator (ICD). Intern Med 43 5 (2004) 360-367
34. Krishen A.S., Leffler J., Wood M., et al. Implantable cardioverter defibrillator T wave oversensing caused by hyperglycemia. Pacing Clin Electrophysiol 24 11 (2001) 1701-1703
35. Russo A., Nayak H., Verdino R., et al. Implantable cardioverter defibrillator events in patients with asymptomatic nonsustained ventricular tachycardia: is device implantation justified?. Pacing Clin Electrophysiol 26 12 (2003) 2289-2295
36. Ellenbogen K., Wood M., Shepard R., et al. Detection and management of an implantable cardioverter defibrillator lead failure: incidence and clinical implications. J Am Coll Cardiol 41 1 (2003) 73-80
37. Gradaus R., Block M., Brachmann J., et al. Mortality, morbidity, and complications in 3344 patients with implantable cardioverter defibrillators: results from the German ICD Registry EURID. Pacing Clin Electrophysiol 26 7 Pt 1 (2003) 1511-1518
38. Garg A., Wadhwa M., Brown K., et al. Inappropriate implantable cardioverter defibrillator discharge from sensing of external alternating current leak. J Interv Card Electrophysiol 7 2 (2002) 181-184
39. Calle P., and Buylaert W. When an AED meets an ICD.... Resuscitation 38 3 (1998) 177-183
40. Anderson K. Sudden cardiac death unresponsive to implantable defibrillator therapy: an urgent target for clinicians, industry and government. J Interv Card Electrophysiol 14 2 (2005) 71-78
41. Berger J. The ethics of deactivating implanted cardioverter defibrillators. Ann Intern Med 142 8 (2005) 631-634
42. Wase A. Random internal component failure of an implantable cardioverter defibrillator. J Interv Card Electrophysiol 10 2 (2004) 175-176
43. Kamke W., Dovifat C., Schranz M., et al. Cardiac rehabilitation in patients with implantable defibrillators. Feasibility and complications. Z Kardiol 92 10 (2003) 869-875
44. Lin G., Nishimura R., Connolly H., et al. Severe symptomatic tricuspid valve regurgitation due to permanent pacemaker or implantable cardioverter-defibrillator leads. J Am Coll Cardiol 17 45 10 (2005) 1672-1675
45. Hauser R., and Kallinen L. Deaths associated with implantable cardioverter defibrillator failure and deactivation reported in the United States Food and Drug Administration Manufacturer and User Facility Device Experience Database. Heart Rhythm 1 4 (2004) 399-405
46. Maisel W. Physician management of pacemaker and implantable cardioverter defibrillator advisories. Pacing Clin Electrophysiol 27 4 (2004) 437-442